Start the New Year by joining the White House Office of Science & Technology Policy (OSTP) and ONC for a robust discussion on the need for a coordinated clinical trials enterprise that can quickly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants.
This virtual session will feature perspectives from several leading industry voices as part of an outreach and engagement strategy designed to collect additional insights under two RFIs published in October, 2022. The deadline for official submissions under both RFIs was extended to January 27, 2023.
Preparing U.S. Clinical Trials Infrastructure for Emergencies: A White House Virtual Roundtable Discussion
On January 12, OSTP hosted a roundtable on clinical trials infrastructure and the emergency clinical trials effort generally. That recording is available here: